Hypercoagulable Disorders in Orthopaedics: Etiology, Considerations, and Management

David Romano1, Maxwell Boyle2, Alexander E Isla2

  • 1Riverside Regional Medical Center, Newport News, Virginia.

JBJS Reviews
|October 12, 2021
PubMed

Insights

Hypercoagulable disorders (HCDs) increase venous thromboembolic event (VTE) risk. Avoid tourniquets in HCD patients during surgery, and monitor closely if their HCD status is unknown.

Area of Science:

  • Hematology
  • Vascular Surgery
  • Thrombosis Research

Background:

  • Hypercoagulable disorders (HCDs), both inherited and acquired, elevate the risk of venous thromboembolic events (VTEs).
  • Diagnosis of HCDs frequently occurs postoperatively due to surgical complications, highlighting a gap in proactive identification.
  • The use of tourniquets in orthopedic surgery for patients with HCDs remains poorly understood and debated.

Purpose of the Study:

  • To review the implications of hypercoagulable disorders in surgical patients.
  • To provide recommendations regarding tourniquet use in orthopedic surgery for patients with known or suspected HCDs.

Main Methods:

  • Literature review and clinical consensus on hypercoagulable disorders and surgical management.
  • Analysis of existing data and case reports concerning tourniquet application in patients with thrombotic tendencies.

Main Results:

  • Hypercoagulable disorders significantly increase the risk of VTEs, often identified after surgical procedures.
  • Tourniquet use in patients with HCDs is associated with potential complications and requires careful consideration.
  • Proactive hematological consultation is crucial for patients with known or suspected HCDs.

Conclusions:

  • Referral to hematological specialists is recommended for HCD workup and management.
  • Tourniquets should be avoided in surgical settings for patients with HCDs whenever feasible.
  • Vigilant postoperative monitoring is essential for patients undergoing surgery with tourniquets, especially when HCD status is uncertain.
Abstract

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
60
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
78
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.5K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
50